Pfizer Inc (PFE)
26.02
-0.62
(-2.33%)
USD |
NYSE |
Jan 22, 16:00
26.12
+0.10
(+0.38%)
Pre-Market: 04:15
Pfizer SG&A Expense (TTM): 15.03B for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
Amgen Inc | 7.492B |
Biogen Inc | 2.332B |
Gilead Sciences Inc | 5.793B |
Regeneron Pharmaceuticals Inc | 2.900B |
Moderna Inc | 1.293B |